Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Minimally Invasive Surgery on Systemic Inflammatory Response in Rectal Cancer

NCT06540027 is registered in ClinicalTrials.gov with Başakşehir Çam & Sakura City Hospital as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06540027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Minimally Invasive Surgery on Systemic Inflammatory Response in Rectal Cancer
Lead sponsor
Başakşehir Çam & Sakura City Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2024
Completion date
March 1, 2025
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenocarcinoma, colorectal cancer, immune system disorder, rectal cancer, rectal cancer stage